Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study

Journal of Human Hypertension volume 22, pages 468–474 (2008)Cite this article

Abstract

The current hypertension (HTN) guidelines recommend the assessment of other cardiovascular disease (CVD) risk factors in individuals with HTN for further management. Few studies in Asian populations have been published to identify the outcome of individuals with HTN and other CVD risk factors. This study aims to assess the effect of HTN alone, and in combination with other CVD risk factors on all-cause and CVD mortality. Three cross-sectional studies carried out in Singapore (baseline 1982–1995) consisting of 5830 persons were grouped by the absence or presence of HTN and CVD risk factors. They were followed-up (mean 14.1 years) by linkage with the National Death Register. Cox's proportional hazards model was used to obtain adjusted hazard ratios (HRs) for risk of mortality. HTN individuals with either <2 CVD risk factors (adjusted HR 1.4; 95% confidence interval (CI) 1.0–1.8) or ⩾2 CVD risk factors (adjusted HR 2.3; 95% CI 1.9–3.0) were at increased risk of all-cause mortality compared to normotensive individuals. The findings were similar for CVD mortality. HTN individuals who also smoked or had diabetes were at highest risk of all-cause mortality, whereas those with elevated total cholesterol/high-density lipoprotein cholesterol, smoked or diabetes had the highest risk for CVD mortality. These findings show that in HTN individuals it is important to assess the presence of other CVD risk factors and manage accordingly.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. World Health Organization. Cardiovascular disease: prevention and control. http://www.who.int/dietphysicalactivity/publications/facts/cvd/en.

  2. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A . Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24: 423–430.

    Article  CAS  Google Scholar 

  3. Kannel WB . Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83–90.

    Article  CAS  Google Scholar 

  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

    Article  CAS  Google Scholar 

  6. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al., British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139–185.

    Article  CAS  Google Scholar 

  7. Stamler J, Stamler R, Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598–615.

    Article  CAS  Google Scholar 

  8. Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I . et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmo Preventive Project. J Intern Med 1996; 239: 489–497.

    Article  CAS  Google Scholar 

  9. Wei M, Mitchell BD, Haffner SM, Stern MP . Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 1996; 144: 1058–1065.

    Article  CAS  Google Scholar 

  10. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95: 1132–1137.

    Article  CAS  Google Scholar 

  11. Keil U, Liese AD, Hense HW, Filipiak B, Doring A, Stieber J et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998; 19: 1197–1207.

    Article  CAS  Google Scholar 

  12. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D . The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000; 342: 1–8.

    Article  CAS  Google Scholar 

  13. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001; 161: 1501–1508.

    Article  CAS  Google Scholar 

  14. Strandberg TE, Salomaa VV, Vanhanen HT, Pitkala K . Blood pressure and mortality during an up to 32-year follow-up. J Hypertens 2001; 19: 35–39.

    Article  CAS  Google Scholar 

  15. Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S, et al., Seven Countries Study. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 2004; 22: 1683–1690.

    Article  CAS  Google Scholar 

  16. Takagi S, Saitoh S, Nakano M, Hayashi Y, Obara F, Onishi H et al. Relationship between blood pressure level and mortality rate: an 18-year study conducted in two rural communities in Japan. J Hypertens 2000; 18: 139–144.

    Article  CAS  Google Scholar 

  17. Lida M, Ueda K, Okayama A, Kodama K, Sawai K, Shibata S, et al., Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese. Nippon data 80. J Hum Hypertens 2003; 17: 851–857.

    Article  Google Scholar 

  18. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al., Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707–716.

    Article  CAS  Google Scholar 

  19. Sairenchi T, Iso H, Irie F, Fukasawa N, Yamagishi K, Kanashiki M et al. Age-specific relationship between blood pressure and the risk of total and cardiovascular mortality in Japanese men and women. Hypertens Res 2005; 28: 901–909.

    Article  Google Scholar 

  20. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005; 112: 3384–3390.

    Article  Google Scholar 

  21. Asia Pacific Cohort Studies Collaboration. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health 2007; 61: 115–121.

    Article  Google Scholar 

  22. Hughes K, Yeo PP, Lun KC, Thai AC, Sothy SP, Wang KW et al. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health 1990; 44: 29–35.

    Article  CAS  Google Scholar 

  23. Tan CE, Emmanuel SC, Tan BY, Jacob E . Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22: 241–247.

    Article  CAS  Google Scholar 

  24. Hughes K, Aw TC, Kuperan P, Choo M . Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997; 51: 394–399.

    Article  CAS  Google Scholar 

  25. Hughes K, Lun KC, Yeo P . Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Commun Health 1990; 44: 24–28.

    Article  CAS  Google Scholar 

  26. Alderman MH, Cohen H, Madhavan S . Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130–1134.

    Article  CAS  Google Scholar 

  27. Zanchetti A, Hansson L, Dahlof B, Elmfeldt D, Kjeldsen S, Kolloch R et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens 2001; 19: 1149–1159.

    Article  CAS  Google Scholar 

  28. Glazer NL, Smith NL, Heckbert SR, Doggen CJ, Lemaitre RN, Psaty BM . Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives. Am J Hypertens 2005; 18: 759–766.

    Article  CAS  Google Scholar 

  29. Ansell BJ . Evidence for a combined approach to the management of hypertension and dyslipidemia. Am J Hypertens 2005; 18: 1249–1257.

    Article  Google Scholar 

  30. Mason RP . A rationale for combination therapy in risk factor management: a mechanistic perspective. Am J Med 2005; 118: 54–61.

    Article  Google Scholar 

  31. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al., ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895–906.

    Article  Google Scholar 

  32. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al., ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149–1158.

    Article  CAS  Google Scholar 

  33. Fogari R, Derosa G, Lazzari P, Zoppi A, Fogari E, Rinaldi A et al. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Am J Hypertens 2004; 17: 823–827.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by an unrestricted educational grant from Pfizer Pte Ltd (Singapore). However, the project was completed independently by the authors.

Author information

Authors and Affiliations

  1. Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    J Lee & K Hughes

  2. Ministry of Health, Singapore

    S Ma, D Heng & S K Chew

  3. Department of Endocrinology, Singapore General Hospital, Singapore

    E S Tai

Authors
  1. J Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Heng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S K Chew
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E S Tai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J., Ma, S., Heng, D. et al. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study. J Hum Hypertens 22, 468–474 (2008). https://doi.org/10.1038/jhh.2008.16

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.16

Keywords

This article is cited by

Search

Advanced search

Quick links